Thursday, February 19, 2015 1:29:56 PM
that is why we are long, we have connected the dots
but here is the rub:
company wants to go to nasdaq, is certain eli 200 will be approved
and marketed, elite even is making preparations and has pictures
of the drug...
but supposedly we dont want to ruffle the feathers of fda so
no road shows, no interviews, no main stream print.
we have a phase 3 trial and main stream investment community
is kept in the dark?
yet the fda has put our company at a stand still and could drag
this out for a long long time giving big pharma the leg up once
again. so what is there to lose by self promotion at this point?
interviews may put heat on fda to stop slowing the approval of eli 200 and fast track it like they said they would.
I am long and not going any where but to be fair and balanced
I dont understand double secret probation concerning letting
the public know who we are and what we have tech wise.
snup was never good at timing when the whales POUNCE BUT
POUNCE THEY WILL, NO LOOK BACK MOVE WILL COME.
It just doesnt add up on some level that is all, or it could
be to let insiders load up, old snup just knows I have a winner
here...
most if not all bio techs I have ever invested in go up when a
phase 3 is announced esp. when company is posturing this is
labeling crossing I's dotting T's type of thing
investors welcome a time line such as one given yesterday
and invest quickly, we are at a stage where 100-million revs
would be in full blown discussions on cnbc, bloomberg etc.
and yet we are still on double secret probation?
well, this will explode in due time..
fair and balanced,
snup dawg
Recent ELTP News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/28/2024 09:23:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/23/2024 12:27:32 PM
- ZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition • InvestorsHub NewsWire • 10/23/2024 12:03:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2024 08:47:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 08:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 09:16:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM